SHANGHAI, China--(BUSINESS WIRE)--The annual trade fair for Chinese pharmaceutical manufacturers, CPhI China (www.cphi-china.com), which closed today after attracting nearly 20,000 visitors from over 20 countries, was the scene for the announcement of a new business initiative by Stravencon Ltd aiming to bridge Chinese life science companies and the European and American pharmaceutical markets. Stravencon Ltd. (www.stravencon.com) is a London-based company with offices in New York and Shanghai dedicated to fostering alliances among healthcare enterprises in Europe, the United States and Asia. Stravencon founder and chief executive, Douglas B. Andrews, described the new venture as follows:
